COSMOS Pharmaceutical CorporationJP:3349Income statement

Market cap
¥611.4B
P/E ratio
19.5x
2011/052012/052013/052014/052015/052016/052017/052018/052019/052020/052021/052022/052023/052024/052025/05
Revenue237,174279,021329,313371,825408,466447,273502,732557,999611,137684,403726,424755,414827,697964,9891,011,390
Cost of revenue---301,268330,391360,420402,688447,681489,353549,419581,313603,966658,979776,683798,109
Gross profit---70,55778,07486,853100,044110,317121,784134,984145,111151,447168,718188,305213,281
Gross margin (%)---
Operating income ---16,70717,08018,64822,23722,74924,77529,09433,14729,79630,12831,50140,404
Operating expenses ---53,84960,99368,20577,80687,56897,008105,890111,964121,651138,589156,804172,877
Income before tax 11,07114,51716,78718,19319,02820,69124,59125,25527,29231,56235,83532,86133,08634,29943,160
Provision for income taxes---7,8157,7258,0617,5227,5347,9548,96711,4399,8928,9759,26511,393
Net income 5,7377,7379,39610,60011,69412,43518,21517,63319,18521,43527,15623,15523,79724,45430,978
Earnings per share289.79390.78474.58535.41590.63628.05919.99890.59968.97541.3685.8584.76600.96617.22390.86
Dividend per share3540505560658090100110708010012070